Monogram Health is a leading kidney disease benefit management and care delivery company. It provides an innovative renal care model and data-driven array of clinical managed services, including complex case and disease management, utilization management, and medication therapy management to transform the delivery of care received by patients living with chronic kidney and end-stage renal disease. Partnering with health plans, physician practices, dialysis providers, and clinically integrated health systems, Monogram Health provides patients with exceptional at-home individualized clinical managed services and nephrology care delivery. Through the use of next generation artificial intelligence, evidence-based criteria, and personalized care planning, Monogram Health's model seeks to delay the progression of the disease, promote a seamless transition to dialysis, palliative care and/or pre-emptive kidney transplant, and optimize health outcomes for patients with end-stage renal disease.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/08/21 | $160,000,000 | Series B |
Frist Cressey Ventures Humana Inc Norwest Venture Partners TPG  | undisclosed |
| 01/09/23 | $375,000,000 |
Cigna Ventures CVS Health Ventures Frist Cressey Ventures Heritage Group Memorial Hermann Health System Norwest Venture Partners Pura Vida Investments SCAN TPG Capital | undisclosed |
